Cart
sales@molnova.com
Citraconic acid
CAS No. 498-23-7
Citraconic acid( Citraconic acid | Citraconsaeure | Kyselina citrakonova | Methylmaleic acid )
Catalog No. M18656 CAS No. 498-23-7
Citraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCitraconic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionCitraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.
-
DescriptionCitraconic acid is a dicarboxylic acid consisting of maleic acid having a methyl substituent at the 2-position.
-
In Vitro——
-
In Vivo——
-
SynonymsCitraconic acid | Citraconsaeure | Kyselina citrakonova | Methylmaleic acid
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number498-23-7
-
Formula Weight130.1
-
Molecular FormulaC5H6O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (768.64 mM)
-
SMILESC/C(=C/C(=O)O)/C(=O)O
-
Chemical Name2-methylfumaric acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ME0328
ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about 7-fold selectivity over PARP1.
-
2,3-Dihydroisoginkge...
2,3-Dihydroisoginkgetin is a Tyrosinase inhibitor with 36.84% inhibition at 0.1 mM.
-
Tafetinib
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
